A1AIA

primidone

Created:2024-03-15
Last modified:  2025-01-22

Find related ligands:

Chemical Details

Formal Charge0
Atom Count30
Chiral Atom Count0
Bond Count31
Aromatic Bond Count6
2D diagram of A1AIA

Chemical Component Summary

Nameprimidone
Synonyms5-ethyl-5-phenyl-1,3-diazinane-4,6-dione
Systematic Name (OpenEye OEToolkits)5-ethyl-5-phenyl-1,3-diazinane-4,6-dione
FormulaC12 H14 N2 O2
Molecular Weight218.252
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01CCC1(C(=O)NCNC1=O)c1ccccc1
SMILESCACTVS3.385CCC1(C(=O)NCNC1=O)c2ccccc2
SMILESOpenEye OEToolkits2.0.7CCC1(C(=O)NCNC1=O)c2ccccc2
Canonical SMILESCACTVS3.385 CCC1(C(=O)NCNC1=O)c2ccccc2
Canonical SMILESOpenEye OEToolkits2.0.7 CCC1(C(=O)NCNC1=O)c2ccccc2
InChIInChI1.06 InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)
InChIKeyInChI1.06 DQMZLTXERSFNPB-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB00794 
NamePrimidone
Groups
  • vet_approved
  • approved
DescriptionPrimidone is an anticonvulsant used to treat essential tremor as well as grand mal, psychomotor, and focal epileptic seizures.[L11112] Primidone was developed by J Yule Bogue and H C Carrington in 1949.[A189522] Primidone was granted FDA Approval on 8 March 1954.[L11112]
Synonyms
  • 2-deoxyphenobarbital
  • Primidonum
  • Primidone
  • Primidona
  • Primidon
Brand Names
  • Mysoline Tab 125mg
  • Mysoline
  • Mysoline 250mg Tab
  • Mysoline Tab 250mg
  • Primidone
IndicationPrimidone is commonly indicated for the management of grand mal, psychomotor, and focal epileptic seizures.[L4645,L11112] In addition, it has also been studied and utilized as an effective management of essential tremor.[A39414,A39415,L4645]
Categories
  • Anti-epileptic Agent
  • Anticholinergic Agents
  • Anticonvulsants
  • Barbiturates
  • Barbiturates and Derivatives
ATC-Code
  • N05CB01
  • N03AA03
CAS number125-33-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Gamma-aminobutyric acid receptor subunit alpha-2MKTKLNIYNMQFLLFVFLVWDPARLVLANIQEDEAKNNITIFTRILDRLL...unknownpotentiator
Gamma-aminobutyric acid receptor subunit alpha-3MIITQTSHCYMTSLGILFLINILPGTTGQGESRRQEPGDFVKQDIGGLSP...unknownpotentiator
Gamma-aminobutyric acid receptor subunit alpha-4MVSAKKVPAIALSAGVSFALLRFLCLAVCLNESPGQNQKEEKLCTENFTR...unknownpotentiator
Gamma-aminobutyric acid receptor subunit alpha-5MDNGMFSGFIMIKNLLLFCISMNLSSHFGFSQMPTSSVKDETNDNITIFT...unknownpotentiator
Gamma-aminobutyric acid receptor subunit alpha-6MASSLPWLCIILWLENALGKLEVEGNFYSENVSRILDNLLEGYDNRLRPG...unknownpotentiator
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL856
PubChem 4909
ChEMBL CHEMBL856
ChEBI CHEBI:8412